264 related articles for article (PubMed ID: 16579673)
1. Use of botulinum toxin type A in children with cerebral palsy.
Nolan KW; Cole LL; Liptak GS
Phys Ther; 2006 Apr; 86(4):573-84. PubMed ID: 16579673
[No Abstract] [Full Text] [Related]
2. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
3. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of spasticity in cerebral palsy with botulinum toxin].
Calderón-González R; Calderón-Sepúlveda RF
Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
[TBL] [Abstract][Full Text] [Related]
5. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
Crowner BE; Racette BA
Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
[TBL] [Abstract][Full Text] [Related]
6. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study.
Zelnik N; Giladi N; Goikhman I; Keren G; Moris R; Honigman S
Isr J Med Sci; 1997 Feb; 33(2):129-33. PubMed ID: 9254875
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
[TBL] [Abstract][Full Text] [Related]
8. Automated feature assessment in instrumented gait analysis.
Wolf S; Loose T; Schablowski M; Döderlein L; Rupp R; Gerner HJ; Bretthauer G; Mikut R
Gait Posture; 2006 Apr; 23(3):331-8. PubMed ID: 15955701
[TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin type A in the treatment plan for cerebral palsy].
Strobl W
Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
[TBL] [Abstract][Full Text] [Related]
10. [Botulinum toxin Type A. Indications and results].
Póo P; López-Casas JA; Galván-Manso M; Aquino-Fariña L; Terricabras-Carol L; Campistol J
Rev Neurol; 2003 Jul 1-15; 37(1):74-80. PubMed ID: 12861515
[TBL] [Abstract][Full Text] [Related]
11. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
Gibson N; Graham HK; Love S
Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin treatment of spastic cerebral palsy].
Hansen LK; Pedersen NR; Westphall IT; Pedersen LT; Jensen H; Villads A
Ugeskr Laeger; 2004 Aug; 166(34):2888-90. PubMed ID: 15449526
[No Abstract] [Full Text] [Related]
14. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
[TBL] [Abstract][Full Text] [Related]
15. Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial.
Kim K; Shin HI; Kwon BS; Kim SJ; Jung IY; Bang MS
Dev Med Child Neurol; 2011 Mar; 53(3):239-44. PubMed ID: 21087238
[TBL] [Abstract][Full Text] [Related]
16. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of "botulinum toxin a" as treatment for children with cerebral palsy: kinematic and kinetic aspects at the ankle joint.
Galli M; Crivellini M; Santambrogio GC; Fazzi E; Motta F
Funct Neurol; 2001; 16(4):317-23. PubMed ID: 11853322
[TBL] [Abstract][Full Text] [Related]
18. The expanding role of botulinum toxin type A injections in the management of children with cerebral palsy.
Carr LJ
Dev Med Child Neurol; 2009 Sep; 51(9):687-8. PubMed ID: 19709139
[No Abstract] [Full Text] [Related]
19. Does botulinum toxin prevent or promote deformity in children with cerebral palsy?
Gough M
Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839
[No Abstract] [Full Text] [Related]
20. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
Voller B; Földy D; Hefter H; Auff E; Schnider P
Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
